Vertex Pharmaceuticals Inc / Ma (VRTX) Shares Issued (2009 - 2026)

Vertex Pharmaceuticals (VRTX) has reported Shares Issued for 18 consecutive years, with $27.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Issued rose 61.68% year-over-year to $27.0 million; the TTM figure through Mar 2026 stood at $138.0 million (up 20.63% YoY), while the FY2025 annual figure was $127.7 million, up 11.43% from the prior year.
• Shares Issued came in at $27.0 million for Q1 2026 at Vertex Pharmaceuticals, down from $54.0 million in the prior quarter.
• The five-year high for Shares Issued was $64.4 million in Q2 2022, with the low at $7.9 million in Q3 2025.
• Average Shares Issued over 5 years is $34.7 million, with a median of $34.3 million recorded in 2024.
• Across the five-year window, Shares Issued soared 165.22% in 2022 and slumped 57.92% in 2023, its largest moves.
• Year by year, Shares Issued stood at $51.6 million in 2022, then retreated by 10.08% to $46.4 million in 2023, then slipped by 26.08% to $34.3 million in 2024, then surged by 57.43% to $54.0 million in 2025, then plunged by 50.0% to $27.0 million in 2026.
• According to Business Quant data, Shares Issued over the past three periods registered $27.0 million, $54.0 million, and $7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.